KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in Net LoansDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Omega Healthcare Investors (OHI) Amortization of Deferred Charges (2018 - 2019)

Historic Amortization of Deferred Charges for Omega Healthcare Investors (OHI) over the last 8 years, with Q3 2019 value amounting to $2.3 million.

  • Omega Healthcare Investors' Amortization of Deferred Charges rose 174.26% to $2.3 million in Q3 2019 from the same period last year, while for Sep 2019 it was $9.0 million, marking a year-over-year increase of 1935.48%. This contributed to the annual value of $35.8 million for FY2015, which is 37769.33% up from last year.
  • Omega Healthcare Investors' Amortization of Deferred Charges amounted to $2.3 million in Q3 2019, which was up 174.26% from $2.2 million recorded in Q2 2019.
  • In the past 5 years, Omega Healthcare Investors' Amortization of Deferred Charges registered a high of $10.7 million during Q1 2015, and its lowest value of $810000.0 during Q2 2015.
  • Over the past 3 years, Omega Healthcare Investors' median Amortization of Deferred Charges value was $2.2 million (recorded in 2018), while the average stood at $3.1 million.
  • The largest annual percentage gain for Omega Healthcare Investors' Amortization of Deferred Charges in the last 5 years was 26225.52% (2015), contrasted with its biggest fall of 7744.36% (2015).
  • Quarter analysis of 3 years shows Omega Healthcare Investors' Amortization of Deferred Charges stood at $810000.0 in 2015, then soared by 176.3% to $2.2 million in 2018, then rose by 1.74% to $2.3 million in 2019.
  • Its last three reported values are $2.3 million in Q3 2019, $2.2 million for Q2 2019, and $2.2 million during Q1 2019.